Baystate Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Baystate Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$3.39K	Hold	38	–	–	﹤0.01%	964
2023 Q3	$2.77K	Hold	38	–	–	﹤0.01%	766
2023 Q2	$3.16K	Hold	38	–	–	﹤0.01%	786
2023 Q1	$2.9K	Buy	+38	New	+$3.15K	﹤0.01%	777
2017 Q3	–	Sell	-150	Closed	-$12K	–	692
2017 Q2	$12K	Hold	150	–	–	﹤0.01%	331
2017 Q1	$10K	Hold	150	–	–	﹤0.01%	338
2016 Q4	$9K	Buy	+150	New	+$9.26K	﹤0.01%	314

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CHP

Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Baystate Wealth Management's XBI Position: Q4 2023 in Review

Baystate Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q4 2023 at 38 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #964.

Baystate Wealth Management first reported a position in XBI in Q4 2016 and has held it in 7 quarters since. The position peaked at $12K in Q2 2017. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

Baystate Wealth Management held 38 shares of State Street SPDR S&P Biotech ETF worth $3.39K as of Q4 2023.
Baystate Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q4 2023.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #964 holding.
Baystate Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 7 quarters since.
Baystate Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $12K in Q2 2017.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.